COVID, One Year Later: What Do We Know Now?

We’re catching up with experts we talked to at the start of the pandemic and asking: what do we know now that we didn’t back then?

CDC guidance on masks:

You might also like:
Why Are Antibody Tests Failing?

Coronavirus Drugs: Where Are We and What’s Next?

How Much Do Cloth Masks Protect You From Getting the Coronavirus?

Moderna COVID Vaccine: 95% Effective (So Far), How Does It Work?

Can Soap REALLY “Kill” the Coronavirus?

Executive Producers:
George Zaidan
Hilary Hudson

Andrew Sobey
Elaine Seward

Sam Jones, PhD

Scientific consultants:
Leila Duman, PhD
Benjamin Neuman, PhD
Brianne Raccor, PhD
Shan Soe-Lin, PhD
Vincent Racaniello, PhD

Continually updated mask guidelines

Scientific Brief: Community Use of Cloth Masks to Control the Spread of SARS-CoV-2

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion

Final report confirms remdesivir benefits for COVID-19,interruptingproductionofthevirus.

Cell entry mechanisms of SARS-CoV-2

US: Fauci says CDC may recommend wearing two masks to fight virus


Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response

Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)

WHO timeline!

Emerging SARS-CoV-2 Variants

Europe’s growing mask ask: Ditch the cloth ones for medical-grade coverings

Time to double or upgrade masks as coronavirus variants emerge, experts say

Antiviral Drugs That Are Approved or Under Evaluation for the Treatment of COVID-19

Produced by the American Chemical Society. Join the American Chemical Society!

Leave a Reply

Your email address will not be published. Required fields are marked *